Drawing upon over 30-years’ experience of serving the glycobiology research community, AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support. Glycobiology (the study of the structure, biosynthesis, and biology of carbohydrates) is a complex and dynamic area of research […]
Alpha Laboratories has introduced the new Polyethylene glycol allergens from BÜHLMANN to the UK. These are for use with the FlowCAST basophil activation assay, providing a safer approach to determine those with a hypersensitivity reaction to PEG. Allergy to Polyethylene glycol (PEG) is rare but can be severe. It is suspected to be the primary cause of allergic reactions in those […]
SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced an exclusive, target-specific license and option agreement with LegoChem Biosciences, a biotechnology company focused on developing its clinical-stage platform technology enabling antibody-drug conjugates (ADCs) with an excellent therapeutic index. SOTIO will obtain rights to deploy LCB’s ADC technology for up to five therapeutic […]
SciRhom GmbH, a therapeutic antibody developer, announced the addition of Dr. Jürgen Reeß to the management team as Chief Medical Officer. At the same time, the company is strengthening its business and scientific strategy with the establishment of a Board of Directors. The three members of the Board, Prof. Carl Blobel, Dr. Wolfgang Baiker, and […]
FUJIFILM Irvine Scientific, a leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, announced the establishment of an Innovation and Collaboration Center in Suzhou New District, China. Through this new centre, experts will collaborate with customers to design upstream cell culture processes that […]
Researchers at Karolinska Institutet in Sweden report that a recently discovered inflammatory mediator, interleukin-26, appears to have an important role in pneumonia and contribute to the killing of bacteria. The study is published in the scientific journal Frontiers in Immunology – Microbial Immunology.
Researchers at Queen’s University Belfast have discovered a new tool, which will help to investigate more effective forms of cancer treatment.
AMSBIO report that researchers from the Medical University of Vienna, have used Lipidure – CM5206 to coat channels in their novel microfluidic devices, to prevent cell adhesion.
H.E.L Group, a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, has released the latest version of its laboratory automation software, labCONSOL 1.2. The new functionality included in the update further enhances the intuitive user experience to increase lab productivity and efficiency, and facilitate process automation.
Takara Bio Europe (TBE) has launched an in vitro diagnostic assay for the qualitative detection of novel coronavirus (SARS-CoV-2) from patients suspected of having Covid-19, based on real-time reverse transcriptase PCR (RT-qPCR). This CE-IVD kit complies with the Directive 98/79/EC on in vitro medical devices and is available for immediate distribution in selected countries.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
